...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Email this morning
3
Aug 17, 2021 08:33AM
4
Aug 17, 2021 10:14AM
5
Aug 17, 2021 10:19AM
3
Aug 17, 2021 08:26PM
5
Aug 18, 2021 11:06AM
3
Aug 18, 2021 01:50PM

Thanks RVXoldtimer for keeping me honest and providing clarity. 

Would it ever be refreshing to see this business run in a clean and less suspicious manner.

So, Newsoara has put the second $5,000,000 USD into shares of ZCC. That seems to be a good sign in terms of some kind of confidence, although it does seem like they are being cautious.

The science seems so promising, thus, it is difficult to reconcile the incredible mess on the business side. The same thought applies to RVX.

No wonder the shares are so undervalued.

Toinv

Share
New Message
Please login to post a reply